UBS ASSET MANAGEMENT AMERICAS INC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2023$177,2560.0%111,4820.0%0.00%
Q1 2023$177,256
-60.3%
111,482
+55.5%
0.00%
Q4 2022$446,660
-99.9%
71,695
+114.2%
0.00%
Q3 2021$403,385,000
-43.0%
33,4760.0%0.00%
Q2 2021$708,017,000
-7.3%
33,476
+22.9%
0.00%
Q1 2021$763,970,000
+27.7%
27,236
+18.4%
0.00%
Q4 2020$598,026,000
-30.1%
23,0010.0%0.00%
Q3 2020$854,947,000
-28.2%
23,001
-0.9%
0.00%
-100.0%
Q2 2020$1,190,803,000
+95.6%
23,208
+20.2%
0.00%
Q1 2020$608,655,000
-51.8%
19,304
-8.8%
0.00%
-100.0%
Q4 2019$1,262,367,000
+63.3%
21,170
+0.4%
0.00%0.0%
Q3 2019$772,866,000
-5.0%
21,082
+20.6%
0.00%0.0%
Q2 2019$813,541,000
+35.2%
17,488
+16.7%
0.00%
Q1 2019$601,849,000
-5.8%
14,990
+7.9%
0.00%
-100.0%
Q4 2018$639,078,000
+53.2%
13,893
+47.8%
0.00%
Q3 2018$417,078,000
+74.5%
9,400
+54.1%
0.00%
Q2 2018$239,059,000
-95.1%
6,100
-90.9%
0.00%
-100.0%
Q1 2018$4,829,764,000
+12.3%
66,774
+2.3%
0.00%0.0%
Q4 2017$4,298,957,000
+115.0%
65,294
+63.7%
0.00%
+100.0%
Q3 2017$1,999,688,000
+10.2%
39,898
+1.8%
0.00%0.0%
Q2 2017$1,814,083,000
-72.5%
39,198
-79.1%
0.00%
-71.4%
Q1 2017$6,608,337,000
+1417998.1%
187,152
+3183.4%
0.01%
Q2 2015$466,000
+22.6%
5,700
+39.0%
0.00%
Q1 2015$380,0004,1000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders